Hepion Pharmaceuticals, Inc. (HEPA)
NASDAQ: HEPA · Real-Time Price · USD
0.2875
-0.0025 (-0.86%)
At close: Apr 25, 2025, 4:00 PM
0.2875
0.00 (0.00%)
Pre-market: Apr 28, 2025, 6:41 AM EDT

Hepion Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-13.19-48.93-42.2-32.72-20.35
Upgrade
Depreciation & Amortization
0.030.070.080.090.03
Upgrade
Other Amortization
1.27----
Upgrade
Asset Writedown & Restructuring Costs
-3.191.87--
Upgrade
Stock-Based Compensation
0.791.342.554.672.38
Upgrade
Other Operating Activities
-4.430.47-0.412.310.15
Upgrade
Change in Accounts Payable
-4.550.32.25-1.073.04
Upgrade
Change in Other Net Operating Assets
1.862.670.91-4.5-1.41
Upgrade
Operating Cash Flow
-18.22-40.89-34.96-31.22-16.17
Upgrade
Capital Expenditures
--0.01-0.02-0.13-0.09
Upgrade
Sale of Property, Plant & Equipment
--0-0
Upgrade
Other Investing Activities
-0.6----
Upgrade
Investing Cash Flow
-0.6-0.01-0.01-0.13-0.09
Upgrade
Long-Term Debt Issued
----0.18
Upgrade
Total Debt Issued
----0.18
Upgrade
Long-Term Debt Repaid
----0.18-
Upgrade
Total Debt Repaid
----0.18-
Upgrade
Net Debt Issued (Repaid)
----0.180.18
Upgrade
Issuance of Common Stock
4.354.49-82.1542.88
Upgrade
Other Financing Activities
---2--
Upgrade
Financing Cash Flow
4.354.49-5.1481.9843.05
Upgrade
Foreign Exchange Rate Adjustments
0.090.01-0.05--
Upgrade
Net Cash Flow
-14.38-36.4-40.1650.6226.8
Upgrade
Free Cash Flow
-18.22-40.9-34.98-31.35-16.25
Upgrade
Free Cash Flow Per Share
-148.23-515.05-458.85-446.07-
Upgrade
Cash Interest Paid
--00-
Upgrade
Levered Free Cash Flow
-14.22-25.88-23.97-15.02-8.69
Upgrade
Unlevered Free Cash Flow
-14.7-25.87-23.96-15.02-8.67
Upgrade
Change in Net Working Capital
3.440.05-0.690.64-1.6
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q